Zetwerk's ₹2,600 Crore IPO Gets SEBI Nod: What Retail Investors Should Know

By ipomarket.in Editorial Team · Last reviewed: 2026-08-14

Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.

Zetwerk, the Bengaluru-based manufacturing services platform, has moved a step closer to its stock market debut. On 14 August 2026 the company filed an Updated Draft Red Herring Prospectus (UDRHP-1) with SEBI, following the regulator's approval of its IPO on 9 July 2026. The offer combines a fresh issue and an offer for sale. Several important details, including the price band, lot size and issue dates, are still not disclosed.

This piece walks through what is confirmed in the regulatory paperwork, what is only reported by the press, and the questions a retail investor would sensibly ask before an offer like this opens.

What has been confirmed so far

A few facts are anchored in official filings and can be treated as settled at this stage:

• SEBI approval: The regulator cleared Zetwerk's IPO on 9 July 2026. A SEBI observation letter is typically valid for 18 months, giving the company a window to launch.
• Route: Zetwerk first filed confidentially through the pre-filing route in March 2026, then published the UDRHP-1 on 14 August 2026.
• Fresh issue: ₹2,600 crore of new capital (reported as roughly $272 million).
• Offer for sale (OFS): 96.8 million shares to be sold by existing shareholders.
• Use of proceeds: ₹1,800 crore earmarked to repay debt, with the balance for general corporate purposes and acquisitions.
• Listing: Shares are proposed to list on both the NSE and BSE.
• Lead bank: Kotak Mahindra Capital is the book running lead manager. Other banks reported to be involved include JM Financial, Avendus Capital, HSBC, Morgan Stanley and Goldman Sachs.

The registrar has not yet been declared, and the price band, lot size and exact open and close dates are not disclosed. These are usually finalised close to launch during the book-building process. As always, an updated draft prospectus is not the same as a live IPO. The company has said it will proceed "subject to market conditions and other approvals."

What is only reported, not confirmed

Press reports citing unnamed sources suggest Zetwerk may begin investor meetings in August 2026 and could target a launch as early as September. This timing is not officially confirmed and can shift with market conditions. Treat any "September" date as a working expectation rather than a fixed calendar entry.

There is also no grey market premium (GMP) yet, because the issue has not been priced or opened. Any GMP figure circulating before a price band exists carries no analytical value. If you are new to how the grey market works, our explainer on what IPO GMP is and how it works sets out why these numbers should be read with caution.

The business in brief

Incorporated in 2017, Zetwerk describes itself as a technology-led global manufacturing platform. It runs a managed marketplace that connects industrial and consumer companies with a network of manufacturing partners for custom and large-scale production.

Key operating facts from the filing and reporting:

• More than 20 manufacturing facilities serving around 1,100 customers.
• Sectors span electronics, energy, capital goods, aerospace and defence, across more than a dozen countries.
• Named customers include Schneider Electric, Indian Oil, Siemens and Acer.
• The business runs through a Manufacturing arm and an Ecosystem arm branded Terra91. Its civil infrastructure business was discontinued in FY26.
• International markets contributed close to 30% of manufacturing revenue in FY26.

Financials: strong growth, but a loss to explain

The headline growth numbers are notable, but so is the FY26 loss.

Revenue grew about 40.4% year on year in FY26. Adjusted EBITDA rose from ₹97 crore in FY24 to ₹421 crore in FY26, and the order book roughly doubled from FY24 levels. At the same time, the company reported a pre-tax loss of ₹916 crore in FY26, attributed to one-off charges. The nature of those charges matters, and investors would want to read the full explanation in the RHP once it is published. A loss driven by genuine one-offs reads very differently from a loss driven by ongoing operations.

The emphasis on debt repayment, ₹1,800 crore of the ₹2,600 crore fresh issue, points to a business that has been capital intensive and carries leverage it wants to reduce. Deleveraging can improve the balance sheet, but it also means a large share of new money is not funding growth directly.

If you want a structured way to read filings like this, our guide on how to analyse IPO financials from the RHP covers what to check beyond headline revenue.

Promoters and selling shareholders

Promoters Amrit Pratik Acharya and Srinath Ramakkrushnan, along with promoter group entity Creovate Innovation, are set to participate in the OFS. Other selling shareholders reportedly include Peak XV, Accel, Lightspeed and Kae Capital. An OFS means these existing holders are selling part of their stakes, so that portion of the money does not go to the company. The scale of promoter and investor selling is worth watching once the final split is disclosed.

Market timing

The filing lands as India's primary market recovers from a subdued first half of 2026, a period affected by geopolitical tension in the Middle East and a spike in crude prices. Reports note that 22 companies have launched or announced IPOs since July, against 27 issues over the January to June period. A firmer market backdrop can help a large offer, but sentiment can change quickly, which is one reason the company has kept its language conditional.

You can track live and upcoming issues on our IPO calendar and follow current grey market activity on the GMP page once pricing details emerge.

Strengths and risks at a glance

Points in favour:

• Rapid revenue growth and a rising, sizeable order book.
• Improving adjusted EBITDA trend across three years.
• A diversified, blue-chip customer base and meaningful international revenue.
• Debt reduction focus, which should lower financial risk after listing.

Points to weigh:

• FY26 pre-tax loss of ₹916 crore; the one-off explanation needs scrutiny.
• Pricing and valuation are unknown, so no reward-versus-price judgement is possible yet.
• A large chunk of fresh capital goes to debt repayment rather than expansion.
• Timing is uncertain and subject to market conditions.

FAQ

When is the Zetwerk IPO date?

The open and close dates are not yet disclosed. Press reports suggest a possible September 2026 launch, but this is unconfirmed and depends on market conditions. Treat it as an expectation, not a fixed date.

What is the Zetwerk IPO price band and lot size?

Neither the price band nor the lot size has been announced. These are typically set close to launch during book-building. Any figures circulating now are speculative.

How big is the issue?

The confirmed structure is a fresh issue of ₹2,600 crore plus an offer for sale of 96.8 million shares by existing shareholders. About ₹1,800 crore of the fresh capital is earmarked for debt repayment.

Is there a GMP for Zetwerk?

No. There is no grey market premium yet because the IPO has not been priced or opened. GMP, in any case, is an informal and unreliable indicator, as our GMP guide explains.

Where will Zetwerk shares list?

The shares are proposed to be listed on both the NSE and the BSE, as stated in the filing.

Bottom line

Zetwerk's IPO is real and progressing: SEBI cleared it in July, and the updated draft prospectus is now on file. What remains open is everything a retail investor needs to make a decision, namely the price band, valuation, dates and the detail behind the FY26 loss. The sensible approach is to wait for the RHP and final pricing before forming any view. Read the offer document carefully when it is published.

Last reviewed: 2026-08-14. Figures are drawn from Zetwerk's regulatory filing and financial press reports; verify against the final RHP before acting.